PROPYLENE GLYCOL

PROPYLENE GLYCOL was reported 3847 times

PROPYLENE GLYCOL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 APPENDICOLITH 88 0.2274
1 SLEEP DISORDER THERAPY 45 0.2273
2 ANTACID THERAPY 25 0.1923
3 CONTAMINATED PRODUCT ADMINISTERED 9 0.1475
4 ANALGESIC THERAPY 46 0.1433
5 DRUG THERAPY 44 0.1298
6 EPIGLOTTIC ERYTHEMA 2 0.1111
7 BACTEROIDES INFECTION 24 0.0920
8 ANTICOAGULANT THERAPY 25 0.0880
9 MALIGNANT MELANOMA STAGE 0 17 0.0813
10 CONGENITAL HIATUS HERNIA 18 0.0789
11 MICROSLEEP 3 0.0750
12 EXPOSURE KERATITIS 2 0.0667
13 BLEPHARORRHAPHY 1 0.0625
14 DIFFUSE LAMELLAR KERATITIS 2 0.0476
15 BILE DUCT STENT REMOVAL 1 0.0370
16 BLOOD FOLATE ABNORMAL 1 0.0303
17 HYPOTENSIVE TRANSFUSION REACTION 2 0.0303
18 HYPERPHOSPHATAEMIA 64 0.0297
19 PRODUCT CONTAMINATION MICROBIAL 33 0.0277
20 BLOOD PHOSPHORUS INCREASED 71 0.0260
21 FOREIGN BODY SENSATION IN EYES 160 0.0251
22 BLOOD OSMOLARITY INCREASED 7 0.0213
23 CORNEAL ENDOTHELIITIS 2 0.0208
24 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 19 0.0205
25 ASTHENOPIA 107 0.0194
26 TOTAL LUNG CAPACITY DECREASED 27 0.0169
27 BLOOD TESTOSTERONE FREE INCREASED 1 0.0167
28 SUPERFICIAL INJURY OF EYE 17 0.0156
29 PERIORBITAL PAIN 13 0.0153
30 EYELID PAIN 28 0.0138
31 IRON DEFICIENCY 57 0.0127
32 BLOOD URIC ACID INCREASED 72 0.0125
33 BLADDER CANCER STAGE 0, WITH CANCER IN SITU 1 0.0120
34 PRODUCT DROPPER ISSUE 9 0.0114
35 INSTILLATION SITE SWELLING 2 0.0114
36 INSTILLATION SITE DISCHARGE 3 0.0114
37 EYE IRRITATION 604 0.0105
38 PNEUMONIA VIRAL 33 0.0103
39 DEAFNESS PERMANENT 2 0.0102
40 TISSUE INFILTRATION 3 0.0102
41 MYASTHENIA GRAVIS 82 0.0101
42 BREATH SOUNDS ABNORMAL 48 0.0097
43 HYPOPHOSPHATAEMIA 71 0.0096
44 LUNG OPACITY 25 0.0095
45 APPENDICITIS 88 0.0094
46 ANORECTAL POLYP 1 0.0093
47 EYE DISCHARGE 96 0.0092
48 AORTIC STENOSIS 31 0.0089
49 VENTRICULAR FIBRILLATION 89 0.0080
50 BLOOD CATECHOLAMINES INCREASED 1 0.0080
51 BREAST FIBROSIS 1 0.0078
52 MYOCARDIAL DEPRESSION 2 0.0078
53 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 39 0.0077
54 EPIGLOTTIC OEDEMA 2 0.0076
55 SCLERAL DISORDER 2 0.0074
56 ASYMPTOMATIC BACTERIURIA 1 0.0074
57 HYPOAESTHESIA EYE 4 0.0068
58 PRODUCT WITH QUALITY ISSUE ADMINISTERED 3 0.0067
59 EYE PAIN 373 0.0066
60 RETINAL DEPIGMENTATION 2 0.0065
61 EYE ALLERGY 10 0.0065
62 CORNEAL INFILTRATES 2 0.0064
63 AORTIC VALVE THICKENING 1 0.0062
64 BLADDER OUTLET OBSTRUCTION 1 0.0061
65 CARDIOGENIC SHOCK 85 0.0059
66 ACUTE RIGHT VENTRICULAR FAILURE 1 0.0059
67 EYELID MARGIN CRUSTING 17 0.0059
68 CORNEAL ABRASION 8 0.0058
69 PLEURITIC PAIN 16 0.0058
70 OCULAR HYPERAEMIA 268 0.0056
71 EYE PRURITUS 181 0.0054
72 PITYRIASIS ROSEA 2 0.0054
73 CORNEAL REFLEX DECREASED 2 0.0053
74 BRONCHIAL IRRITATION 1 0.0052
75 OCULAR DISCOMFORT 56 0.0050
76 BILIARY CIRRHOSIS 1 0.0050
77 RESPIRATORY SYMPTOM 14 0.0049
78 REACTION TO PRESERVATIVES 4 0.0049
79 LICHENIFICATION 2 0.0049
80 EYELID IRRITATION 12 0.0048
81 TROPONIN INCREASED 35 0.0046
82 DRY EYE 224 0.0045
83 PLASMACYTOMA 8 0.0043
84 ADRENAL NEOPLASM 2 0.0043
85 ERYTHEMA OF EYELID 23 0.0042
86 INSTILLATION SITE IRRITATION 5 0.0042
87 PRODUCT DESIGN ISSUE 3 0.0042
88 BLOOD BICARBONATE INCREASED 2 0.0042
89 CANCER IN REMISSION 1 0.0041
90 ASPARTATE AMINOTRANSFERASE 1 0.0041
91 BODY MASS INDEX ABNORMAL 1 0.0041
92 BENIGN PROSTATIC HYPERPLASIA 21 0.0041
93 ROOT CANAL INFECTION 2 0.0041
94 LIQUID PRODUCT PHYSICAL ISSUE 29 0.0040
95 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 68 0.0040
96 BLEPHARAL PIGMENTATION 2 0.0040
97 ABNORMAL SENSATION IN EYE 17 0.0040
98 BLOOD CALCIUM INCREASED 34 0.0039
99 INJURY CORNEAL 2 0.0038
100 LACRIMATION INCREASED 116 0.0038
101 CARDIAC MURMUR 33 0.0038
102 ANION GAP INCREASED 5 0.0037
103 ATRIAL ENLARGEMENT 1 0.0037
104 BACTERIAL INFECTION 68 0.0036
105 REACTION TO EXCIPIENT 8 0.0035
106 ENDOCRINE OPHTHALMOPATHY 3 0.0035
107 AMBLYOPIA 2 0.0034
108 MULTIPLE ORGAN DYSFUNCTION SYNDROME 95 0.0034
109 BLOOD CREATINE DECREASED 1 0.0033
110 EYELID SKIN DRYNESS 4 0.0033
111 BLOOD BICARBONATE DECREASED 6 0.0032
112 BREAST CELLULITIS 1 0.0032
113 PRODUCT AFTER TASTE 3 0.0031
114 NEURALGIA 76 0.0031
115 STAPHYLOCOCCAL ABSCESS 2 0.0031
116 HYPERLIPIDAEMIA 37 0.0031
117 OCULAR HYPERTENSION 6 0.0031
118 ANTICONVULSANT DRUG LEVEL ABOVE THERAPEUTIC 2 0.0031
119 EYELID RASH 3 0.0031
120 GINGIVAL DISCOMFORT 2 0.0030
121 ASCITES 89 0.0030
122 EYELIDS PRURITUS 9 0.0029
123 OPHTHALMIC MIGRAINE 2 0.0029
124 EYE OEDEMA 7 0.0029
125 ACQUIRED DIAPHRAGMATIC EVENTRATION 1 0.0028
126 LIP EROSION 2 0.0027
127 MEDICATION RESIDUE PRESENT 13 0.0027
128 PRODUCT PACKAGE ASSOCIATED INJURY 6 0.0027
129 ACUTE PHASE REACTION 1 0.0026
130 BONE TUBERCULOSIS 1 0.0026
131 CORNEAL TRANSPLANT 2 0.0026
132 ULCER 40 0.0025
133 ALLERGIC REACTION TO EXCIPIENT 5 0.0025
134 PHOTOPHOBIA 47 0.0025
135 PLASMA CELL MYELOMA RECURRENT 8 0.0025
136 BLADDER PROLAPSE 3 0.0025
137 VISION BLURRED 328 0.0024
138 BLOOD TEST ABNORMAL 33 0.0023
139 GOUT 42 0.0023
140 BLOOD HOMOCYSTEINE INCREASED 1 0.0023
141 KERATITIS 7 0.0023
142 PRODUCT CONTAINER SEAL ISSUE 4 0.0023
143 BLADDER HYPERTROPHY 1 0.0023
144 GASTROENTERITIS 33 0.0023
145 END STAGE RENAL DISEASE 41 0.0022
146 ALLERGY TO ARTHROPOD STING 1 0.0022
147 PUNCTATE KERATITIS 2 0.0022
148 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 109 0.0021
149 ARTIFICIAL CROWN PROCEDURE 1 0.0020
150 INSTILLATION SITE PAIN 5 0.0020
151 DERMATITIS EXFOLIATIVE GENERALISED 7 0.0020
152 ASPIRATION 22 0.0020
153 EYE INFLAMMATION 19 0.0020
154 SUSPECTED PRODUCT CONTAMINATION 2 0.0020
155 ASPARTATE AMINOTRANSFERASE DECREASED 1 0.0019
156 EOSINOPHILIA 33 0.0019
157 PRODUCT COMMINGLING 2 0.0019
158 ALBUMINURIA 1 0.0019
159 PRODUCT NAME CONFUSION 2 0.0018
160 ULCERATIVE KERATITIS 5 0.0018
161 BLOOD PH INCREASED 1 0.0018
162 FULL BLOOD COUNT ABNORMAL 19 0.0018
163 EYE INFECTION 20 0.0018
164 HYPERCHOLESTEROLAEMIA 17 0.0018
165 BLOOD PH DECREASED 3 0.0018
166 SWELLING OF EYELID 11 0.0018
167 BLEPHARITIS 7 0.0017
168 EYELID DISORDER 4 0.0017
169 FOLATE DEFICIENCY 2 0.0017
170 EYELID OEDEMA 20 0.0017
171 SINUS OPERATION 4 0.0017
172 HYPONATRAEMIA 93 0.0016
173 ORAL MUCOSA EROSION 2 0.0016
174 METAMORPHOPSIA 3 0.0016
175 PRESYNCOPE 39 0.0016
176 PERIORBITAL SWELLING 9 0.0016
177 BLOOD CHOLESTEROL INCREASED 73 0.0016
178 ADENOCARCINOMA PANCREAS 2 0.0016
179 RALES 9 0.0015
180 LOWER RESPIRATORY TRACT INFECTION 69 0.0015
181 EYE SWELLING 56 0.0015
182 MICTURITION URGENCY 17 0.0015
183 NASAL DISCHARGE DISCOLOURATION 2 0.0014
184 PRODUCT PHYSICAL CONSISTENCY ISSUE 8 0.0014
185 OBSTRUCTIVE AIRWAYS DISORDER 16 0.0014
186 THERAPEUTIC PROCEDURE 2 0.0014
187 UPPER RESPIRATORY TRACT INFECTION 66 0.0014
188 ALCOHOL INTOLERANCE 1 0.0014
189 HORDEOLUM 6 0.0014
190 REACTION TO DRUG EXCIPIENTS 3 0.0014
191 BLUNTED AFFECT 1 0.0014
192 BRONCHIECTASIS 9 0.0013
193 EXPIRED PRODUCT ADMINISTERED 44 0.0013
194 AGE-RELATED MACULAR DEGENERATION 2 0.0013
195 EYE INJURY 4 0.0013
196 ASPIRATION PLEURAL CAVITY 1 0.0013
197 ALLERGIC COUGH 1 0.0013
198 ANTICOAGULATION DRUG LEVEL BELOW THERAPEUTIC 1 0.0013
199 ORAL MUCOSAL ERYTHEMA 2 0.0013
200 PRODUCT CONTAINER ISSUE 11 0.0013
201 MULTIPLE USE OF SINGLE-USE PRODUCT 7 0.0012
202 PRODUCT QUALITY ISSUE 169 0.0012
203 SHOULDER FRACTURE 2 0.0012
204 ALTERED VISUAL DEPTH PERCEPTION 1 0.0012
205 IRON DEFICIENCY ANAEMIA 11 0.0012
206 PULMONARY EMBOLISM 112 0.0012
207 ALLERGIC SINUSITIS 1 0.0012
208 TREATMENT DELAYED 2 0.0012
209 ALCOHOL WITHDRAWAL SYNDROME 1 0.0011
210 SLEEP DISORDER 81 0.0011
211 BLOOD POTASSIUM ABNORMAL 3 0.0011
212 CONJUNCTIVAL HYPERAEMIA 4 0.0011
213 ABDOMINAL NEOPLASM 1 0.0011
214 PRODUCT DELIVERY MECHANISM ISSUE 6 0.0011
215 BLEPHAROSPASM 7 0.0011
216 BLOOD MAGNESIUM INCREASED 1 0.0011
217 ESSENTIAL HYPERTENSION 2 0.0011
218 DRY MOUTH 88 0.0011
219 BLOOD ALKALINE PHOSPHATASE DECREASED 1 0.0011
220 OSTEOPOROTIC FRACTURE 2 0.0010
221 PATIENT DISSATISFACTION WITH TREATMENT 2 0.0010
222 BLOOD URINE 1 0.0010
223 THROMBOSIS 83 0.0010
224 ANIMAL SCRATCH 1 0.0010
225 ANTISOCIAL BEHAVIOUR 1 0.0010
226 DIABETES MELLITUS 76 0.0010
227 HYPOPHYSITIS 2 0.0010
228 VITAMIN B12 DEFICIENCY 4 0.0010
229 BREAST ABSCESS 1 0.0010
230 LIVER FUNCTION TEST INCREASED 21 0.0010
231 DUODENITIS 3 0.0010
232 BODY TEMPERATURE FLUCTUATION 2 0.0010
233 SEPSIS 107 0.0010
234 SPUTUM DISCOLOURED 9 0.0009
235 BONE DEMINERALISATION 1 0.0009
236 BLOOD SODIUM ABNORMAL 1 0.0009
237 JOINT INJURY 20 0.0009
238 CATHETER SITE ERYTHEMA 2 0.0009
239 OCULOGYRIC CRISIS 2 0.0009
240 VITREOUS DETACHMENT 2 0.0009
241 FACET JOINT SYNDROME 3 0.0009
242 ABDOMINAL DISTENSION 96 0.0009
243 DIVERTICULUM INTESTINAL 4 0.0009
244 INTENTIONAL PRODUCT MISUSE 77 0.0009
245 BLOOD PRESSURE SYSTOLIC DECREASED 4 0.0009
246 BLOOD FIBRINOGEN DECREASED 1 0.0009
247 ARTERIAL HAEMORRHAGE 1 0.0009
248 INTRAOCULAR PRESSURE INCREASED 11 0.0009
249 BLADDER OPERATION 1 0.0009
250 TRANSAMINASES INCREASED 19 0.0009
251 SWELLING 78 0.0008
252 RADIUS FRACTURE 2 0.0008
253 BRONCHIAL HYPERREACTIVITY 1 0.0008
254 BLOOD IMMUNOGLOBULIN E INCREASED 2 0.0008
255 CATARACT 49 0.0008
256 BLOOD PRESSURE SYSTOLIC ABNORMAL 2 0.0008
257 DRUG INTOLERANCE 78 0.0008
258 GENERAL PHYSICAL HEALTH DETERIORATION 93 0.0008
259 PRE-EXISTING CONDITION IMPROVED 5 0.0008
260 EXCORIATION 2 0.0008
261 APPLICATION SITE WARMTH 1 0.0008
262 PRODUCT COLOUR ISSUE 4 0.0008
263 SEASONAL ALLERGY 11 0.0008
264 BLOOD CHLORIDE DECREASED 2 0.0008
265 PRODUCTIVE COUGH 37 0.0008
266 ADJUSTMENT DISORDER 1 0.0008
267 APPLICATION SITE PARAESTHESIA 1 0.0008
268 PROSTATOMEGALY 3 0.0008
269 POOR QUALITY PRODUCT ADMINISTERED 8 0.0008
270 ACROCHORDON 1 0.0008
271 EYE HAEMORRHAGE 10 0.0007
272 NASAL CONGESTION 44 0.0007
273 PULMONARY MASS 11 0.0007
274 VITREOUS FLOATERS 7 0.0007
275 BLOOD ELECTROLYTES DECREASED 1 0.0007
276 INTERVERTEBRAL DISC DISORDER 3 0.0007
277 DERMATITIS ATOPIC 37 0.0007
278 TUMOUR HAEMORRHAGE 2 0.0007
279 WHEEZING 41 0.0007
280 TOOTH INJURY 3 0.0007
281 DYSPNOEA AT REST 2 0.0007
282 BILIARY COLIC 2 0.0007
283 PULMONARY PAIN 2 0.0007
284 CYTOMEGALOVIRUS INFECTION REACTIVATION 3 0.0007
285 BLOOD PARATHYROID HORMONE DECREASED 1 0.0007
286 AXILLARY PAIN 1 0.0007
287 ODYNOPHAGIA 4 0.0007
288 SUSPECTED OFF LABEL USE 3 0.0007
289 DRUG TOXICITY 9 0.0007
290 CORONARY ARTERY DISEASE 20 0.0007
291 ASTIGMATISM 1 0.0007
292 BLOOD CREATININE INCREASED 43 0.0007
293 BRAIN NATRIURETIC PEPTIDE INCREASED 2 0.0006
294 ARTHRITIS INFECTIVE 3 0.0006
295 ROSACEA 3 0.0006
296 INFUSION SITE EXTRAVASATION 4 0.0006
297 PLEURAL EFFUSION 39 0.0006
298 PRODUCT ADMINISTRATION INTERRUPTED 5 0.0006
299 ABDOMINAL ADHESIONS 2 0.0006
300 IRIDOCYCLITIS 2 0.0006
301 ANALGESIC DRUG LEVEL INCREASED 1 0.0006
302 OEDEMA PERIPHERAL 74 0.0006
303 BLOOD CALCIUM ABNORMAL 1 0.0006
304 PLANTAR FASCIITIS 2 0.0006
305 TRANSIENT ISCHAEMIC ATTACK 20 0.0006
306 PRODUCT LABEL ISSUE 4 0.0006
307 PUSTULAR PSORIASIS 2 0.0006
308 ACUTE SINUSITIS 1 0.0006
309 PERIORBITAL OEDEMA 3 0.0006
310 VISUAL ACUITY REDUCED 19 0.0006
311 PRODUCT USE COMPLAINT 9 0.0006
312 BLOOD LACTIC ACID INCREASED 3 0.0006
313 ASPARTATE AMINOTRANSFERASE INCREASED 30 0.0006
314 FOOD POISONING 3 0.0006
315 CARDIAC ABLATION 1 0.0006
316 SINUS DISORDER 11 0.0006
317 CARDIOVASCULAR DISORDER 14 0.0006
318 MONOCYTE COUNT INCREASED 2 0.0006
319 SCLERODERMA 2 0.0005
320 DEAFNESS UNILATERAL 3 0.0005
321 PARADOXICAL DRUG REACTION 2 0.0005
322 BLINDNESS TRANSIENT 4 0.0005
323 BLOOD PRESSURE DIASTOLIC DECREASED 4 0.0005
324 WOUND HAEMORRHAGE 2 0.0005
325 AURA 1 0.0005
326 ASTHMA 60 0.0005
327 SNORING 2 0.0005
328 PARANASAL SINUS DISCOMFORT 2 0.0005
329 SOMNOLENCE 106 0.0005
330 CONJUNCTIVAL HAEMORRHAGE 2 0.0005
331 PULMONARY FIBROSIS 10 0.0005
332 CONSTIPATION 113 0.0005
333 MADAROSIS 6 0.0005
334 DEVICE USE ISSUE 9 0.0005
335 SPINAL CORD COMPRESSION 2 0.0005
336 VITAMIN D DEFICIENCY 5 0.0005
337 NASAL DISCOMFORT 4 0.0005
338 ANAEMIA 96 0.0005
339 MUSCULOSKELETAL STIFFNESS 44 0.0005
340 DYSPHAGIA 47 0.0005
341 LACTIC ACIDOSIS 16 0.0005
342 TOOTH ABSCESS 5 0.0005
343 EYE DISORDER 16 0.0005
344 EXTRAVASATION 2 0.0005
345 ANAPHYLACTOID REACTION 2 0.0005
346 SPINAL STENOSIS 2 0.0005
347 RED CELL DISTRIBUTION WIDTH INCREASED 2 0.0005
348 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 34 0.0005
349 ABDOMINAL PAIN 111 0.0005
350 INFUSION SITE SWELLING 3 0.0005
351 ATTENTION DEFICIT HYPERACTIVITY DISORDER 2 0.0005
352 PHOTOPSIA 3 0.0005
353 HAEMOGLOBIN ABNORMAL 3 0.0005
354 HAEMOPTYSIS 13 0.0005
355 POLYP 3 0.0005
356 SOMNAMBULISM 3 0.0005
357 LIGAMENT RUPTURE 2 0.0005
358 BACTERIAL TEST POSITIVE 1 0.0004
359 LEFT VENTRICULAR DYSFUNCTION 3 0.0004
360 DYSPEPSIA 44 0.0004
361 URINE ABNORMALITY 2 0.0004
362 METABOLIC ACIDOSIS 14 0.0004
363 ONYCHOCLASIS 3 0.0004
364 ISCHAEMIA 2 0.0004
365 EYE OPERATION 2 0.0004
366 ENCEPHALITIS 3 0.0004
367 NEPHROGENIC ANAEMIA 2 0.0004
368 UMBILICAL HERNIA 2 0.0004
369 SKIN REACTION 6 0.0004
370 COVID-19 PNEUMONIA 5 0.0004
371 DIVERTICULUM 3 0.0004
372 CHOLECYSTITIS 5 0.0004
373 SLEEP APNOEA SYNDROME 8 0.0004
374 SUPRAVENTRICULAR TACHYCARDIA 4 0.0004
375 FEBRILE NEUTROPENIA 27 0.0004
376 BODY TEMPERATURE DECREASED 4 0.0004
377 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 1 0.0004
378 CONDITION AGGRAVATED 123 0.0004
379 MULTIPLE DRUG OVERDOSE 2 0.0004
380 INJECTION SITE INFLAMMATION 2 0.0004
381 SALIVARY HYPERSECRETION 4 0.0004
382 PRODUCT ADMINISTRATION ERROR 8 0.0004
383 BRAIN ABSCESS 1 0.0004
384 BLOOD PRESSURE DIASTOLIC ABNORMAL 1 0.0004
385 PHLEBITIS 2 0.0004
386 CONCUSSION 3 0.0004
387 FAILURE TO THRIVE 2 0.0004
388 DIPLOPIA 10 0.0004
389 VISUAL IMPAIRMENT 47 0.0004
390 SERUM FERRITIN INCREASED 2 0.0004
391 FURUNCLE 3 0.0004
392 OSTEOARTHRITIS 16 0.0004
393 COMPRESSION FRACTURE 2 0.0004
394 INJECTION SITE DISCHARGE 2 0.0004
395 HYPOXIA 13 0.0004
396 OESOPHAGITIS 4 0.0004
397 JAW DISORDER 2 0.0004
398 GLAUCOMA 7 0.0004
399 HUNGER 5 0.0004
400 VITAMIN D DECREASED 3 0.0004
401 DERMATITIS CONTACT 4 0.0004
402 SKIN ATROPHY 2 0.0003
403 ENTEROCOLITIS 2 0.0003
404 HYPERVENTILATION 2 0.0003
405 PULMONARY ARTERIAL HYPERTENSION 5 0.0003
406 ORTHOSTATIC HYPOTENSION 6 0.0003
407 METABOLIC DISORDER 2 0.0003
408 URINE OUTPUT DECREASED 3 0.0003
409 PRODUCT LABEL CONFUSION 2 0.0003
410 NAIL DISORDER 3 0.0003
411 DYSSTASIA 10 0.0003
412 SPINAL OSTEOARTHRITIS 3 0.0003
413 LIVER DISORDER 15 0.0003
414 SKIN HAEMORRHAGE 5 0.0003
415 CATARACT OPERATION 2 0.0003
416 IMMUNODEFICIENCY 5 0.0003
417 MACULAR DEGENERATION 4 0.0003
418 BRAIN HERNIATION 1 0.0003
419 HYPERTENSION 70 0.0003
420 VOMITING 155 0.0003
421 ATRIOVENTRICULAR BLOCK SECOND DEGREE 1 0.0003
422 RETCHING 7 0.0003
423 DIVERTICULITIS 9 0.0003
424 THINKING ABNORMAL 6 0.0003
425 FLANK PAIN 3 0.0003
426 SECRETION DISCHARGE 4 0.0003
427 NASAL DRYNESS 2 0.0003
428 PRODUCT PACKAGING ISSUE 3 0.0003
429 BLADDER PAIN 1 0.0003
430 BILE DUCT STONE 1 0.0003
431 ANGINA UNSTABLE 2 0.0003
432 PHARYNGEAL SWELLING 3 0.0003
433 BRADYPHRENIA 2 0.0003
434 KNEE OPERATION 3 0.0003
435 HYPOGAMMAGLOBULINAEMIA 2 0.0003
436 SHOCK 7 0.0003
437 ORAL CANDIDIASIS 4 0.0003
438 LIGAMENT SPRAIN 3 0.0003
439 PRODUCT FORMULATION ISSUE 2 0.0003
440 VENTRICULAR TACHYCARDIA 5 0.0003
441 POST-TRAUMATIC STRESS DISORDER 2 0.0003
442 WRONG PRODUCT ADMINISTERED 2 0.0003
443 NEUTROPHIL COUNT INCREASED 3 0.0003
444 SINUSITIS 30 0.0003
445 HAIR GROWTH ABNORMAL 2 0.0003
446 VENTRICULAR EXTRASYSTOLES 3 0.0003
447 LARGE INTESTINE POLYP 2 0.0003
448 TENDERNESS 3 0.0003
449 ORAL DISCOMFORT 4 0.0003
450 AUTOIMMUNE HEPATITIS 2 0.0003
451 APHONIA 4 0.0003
452 MASS 4 0.0003
453 LUNG DISORDER 14 0.0003
454 CARPAL TUNNEL SYNDROME 4 0.0003
455 RIGHT VENTRICULAR FAILURE 2 0.0003
456 BLINDNESS UNILATERAL 4 0.0003
457 SUDDEN DEATH 3 0.0003
458 DUODENAL ULCER 2 0.0003
459 ACUTE RESPIRATORY DISTRESS SYNDROME 5 0.0003
460 THERMAL BURN 2 0.0003
461 DYSPNOEA 159 0.0003
462 BRONCHOSPASM 4 0.0003
463 IMPAIRED QUALITY OF LIFE 4 0.0003
464 BONE LESION 1 0.0003
465 PHARYNGITIS STREPTOCOCCAL 3 0.0003
466 VISUAL FIELD DEFECT 2 0.0003
467 FLUID OVERLOAD 4 0.0003
468 MAJOR DEPRESSION 2 0.0003
469 ACCIDENTAL OVERDOSE 10 0.0003
470 ORAL DISORDER 2 0.0003
471 PSYCHIATRIC SYMPTOM 2 0.0003
472 BLOOD GLUCOSE ABNORMAL 5 0.0003
473 MEDICAL DEVICE COMPLICATION 2 0.0003
474 GASTROINTESTINAL DISORDER 24 0.0003
475 THROAT IRRITATION 12 0.0003
476 GASTRITIS 7 0.0003
477 DYSPNOEA EXERTIONAL 10 0.0003
478 BLOOD SODIUM DECREASED 5 0.0003
479 AUTOIMMUNE THYROIDITIS 1 0.0003
480 SCAB 3 0.0003
481 HAEMODYNAMIC INSTABILITY 2 0.0003
482 NAUSEA 207 0.0003
483 BOWEL MOVEMENT IRREGULARITY 2 0.0003
484 FOOD ALLERGY 2 0.0003
485 BLOOD PRESSURE SYSTOLIC INCREASED 5 0.0003
486 BRAIN FOG 4 0.0003
487 MULTIPLE ALLERGIES 2 0.0003
488 PRODUCT USE IN UNAPPROVED INDICATION 63 0.0003
489 HEAD INJURY 8 0.0003
490 BLOOD ALBUMIN DECREASED 2 0.0003
491 TRICUSPID VALVE INCOMPETENCE 2 0.0003
492 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 45 0.0002
493 GASTROOESOPHAGEAL REFLUX DISEASE 20 0.0002
494 BURSITIS 3 0.0002
495 TREMOR 41 0.0002
496 DISCOMFORT 15 0.0002
497 DECUBITUS ULCER 2 0.0002
498 POLYURIA 2 0.0002
499 GLOMERULAR FILTRATION RATE DECREASED 3 0.0002
500 ARTHRITIS BACTERIAL 1 0.0002
501 ESCHERICHIA INFECTION 2 0.0002
502 RIB FRACTURE 5 0.0002
503 APPLICATION SITE EXFOLIATION 1 0.0002
504 DYSGEUSIA 18 0.0002
505 SPINAL COMPRESSION FRACTURE 2 0.0002
506 CYST 3 0.0002
507 VIRAL INFECTION 8 0.0002
508 HAEMODIALYSIS 2 0.0002
509 BUNDLE BRANCH BLOCK LEFT 1 0.0002
510 AORTIC VALVE INCOMPETENCE 1 0.0002
511 MYDRIASIS 3 0.0002
512 UNRESPONSIVE TO STIMULI 6 0.0002
513 SKIN ULCER 6 0.0002
514 DRUG INEFFECTIVE 303 0.0002
515 GROIN PAIN 2 0.0002
516 TOOTH INFECTION 3 0.0002
517 IMMUNOSUPPRESSION 2 0.0002
518 BLOOD CREATINE INCREASED 1 0.0002
519 EAR INFECTION 6 0.0002
520 TOXICITY TO VARIOUS AGENTS 38 0.0002
521 FACIAL PAIN 2 0.0002
522 INCORRECT ROUTE OF DRUG ADMINISTRATION 8 0.0002
523 ANAL INCONTINENCE 2 0.0002
524 SINUS CONGESTION 3 0.0002
525 PRODUCT TASTE ABNORMAL 3 0.0002
526 OROPHARYNGEAL DISCOMFORT 2 0.0002
527 LIMB INJURY 6 0.0002
528 IMPAIRED GASTRIC EMPTYING 3 0.0002
529 ABDOMINAL HERNIA 1 0.0002
530 CORONARY ARTERY OCCLUSION 3 0.0002
531 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 4 0.0002
532 RETINAL DETACHMENT 2 0.0002
533 URINARY TRACT INFECTION 37 0.0002
534 INTENTIONAL PRODUCT USE ISSUE 19 0.0002
535 NERVE COMPRESSION 2 0.0002
536 BLOOD CHOLESTEROL ABNORMAL 1 0.0002
537 INTERVERTEBRAL DISC DEGENERATION 2 0.0002
538 CONJUNCTIVITIS 4 0.0002
539 DEFORMITY 2 0.0002
540 CHOLELITHIASIS 7 0.0002
541 LACERATION 2 0.0002
542 ARTERIOSCLEROSIS 2 0.0002
543 HYPOCALCAEMIA 4 0.0002
544 BLOOD URINE PRESENT 4 0.0002
545 INTENTIONAL DOSE OMISSION 6 0.0002
546 HYPERSENSITIVITY 39 0.0002
547 THERAPY INTERRUPTED 15 0.0002
548 RED BLOOD CELL COUNT DECREASED 6 0.0002
549 HERPES ZOSTER 12 0.0002
550 LOWER LIMB FRACTURE 4 0.0002
551 PYREXIA 72 0.0002
552 ACUTE RESPIRATORY FAILURE 4 0.0002
553 HERNIA 4 0.0002
554 EAR PAIN 4 0.0002
555 AUTOIMMUNE DISORDER 2 0.0002
556 HAEMORRHOIDS 4 0.0002
557 CHOKING 4 0.0002
558 SKIN FISSURES 4 0.0002
559 HOSPICE CARE 2 0.0002
560 DRUG EFFECT LESS THAN EXPECTED 3 0.0002
561 HAEMATOCRIT DECREASED 4 0.0002
562 BLADDER DISORDER 2 0.0002
563 RHINORRHOEA 13 0.0002
564 ANEURYSM 1 0.0002
565 HAEMORRHAGE INTRACRANIAL 3 0.0002
566 APPLICATION SITE SWELLING 1 0.0002
567 EPISTAXIS 15 0.0002
568 PNEUMONIA ASPIRATION 5 0.0002
569 HYPOTENSION 40 0.0002
570 OSTEOPENIA 3 0.0002
571 EYELID PTOSIS 2 0.0002
572 DRY THROAT 2 0.0002
573 BALANCE DISORDER 17 0.0002
574 DRUG DISPENSING ERROR 3 0.0002
575 AMMONIA INCREASED 1 0.0002
576 HOSPITALISATION 30 0.0002
577 PHARYNGEAL OEDEMA 3 0.0002
578 CACHEXIA 1 0.0002
579 MUSCULOSKELETAL CHEST PAIN 3 0.0002
580 TENDONITIS 3 0.0002
581 POOR VENOUS ACCESS 2 0.0002
582 DELUSION 3 0.0002
583 EJECTION FRACTION DECREASED 3 0.0002
584 PULMONARY HYPERTENSION 4 0.0002
585 PRODUCT ODOUR ABNORMAL 2 0.0002
586 DERMATITIS 4 0.0002
587 CYANOSIS 3 0.0002
588 PRODUCT DOSE OMISSION ISSUE 56 0.0002
589 INCONTINENCE 2 0.0002
590 JOINT DISLOCATION 2 0.0002
591 PNEUMOTHORAX 3 0.0002
592 COUGH 53 0.0002
593 OBESITY 3 0.0002
594 DYSPHONIA 11 0.0002
595 BODY HEIGHT DECREASED 2 0.0002
596 HIP FRACTURE 6 0.0002
597 HYPOACUSIS 8 0.0002
598 BEHAVIOUR DISORDER 1 0.0002
599 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 37 0.0002
600 STAPHYLOCOCCAL INFECTION 6 0.0002
601 HEADACHE 114 0.0002
602 GASTROINTESTINAL PAIN 2 0.0002
603 MELAENA 4 0.0002
604 AUTISM SPECTRUM DISORDER 1 0.0002
605 TOOTH FRACTURE 2 0.0002
606 THERAPEUTIC RESPONSE SHORTENED 6 0.0002
607 DENTAL CARIES 2 0.0002
608 PSYCHOMOTOR HYPERACTIVITY 3 0.0002
609 RED BLOOD CELL SEDIMENTATION RATE INCREASED 2 0.0002
610 FOOT DEFORMITY 2 0.0002
611 FEELING COLD 5 0.0002
612 OFF LABEL USE 157 0.0002
613 PULMONARY OEDEMA 8 0.0002
614 SKIN INFECTION 2 0.0002
615 OXYGEN SATURATION DECREASED 10 0.0002
616 BLOOD CALCIUM DECREASED 2 0.0002
617 CANDIDA INFECTION 3 0.0002
618 PNEUMONIA 57 0.0002
619 IMPAIRED DRIVING ABILITY 2 0.0002
620 BRONCHITIS 13 0.0002
621 SKIN DISCOLOURATION 8 0.0002
622 HALLUCINATION 13 0.0002
623 ELECTROLYTE IMBALANCE 2 0.0002
624 HEART RATE DECREASED 6 0.0002
625 SPLENOMEGALY 2 0.0002
626 SPINAL PAIN 2 0.0002
627 COLD SWEAT 3 0.0002
628 OSTEOPOROSIS 7 0.0002
629 LYMPHOCYTE COUNT DECREASED 3 0.0002
630 DRUG ERUPTION 3 0.0002
631 ACCIDENT 2 0.0002
632 ROAD TRAFFIC ACCIDENT 7 0.0002
633 DISTURBANCE IN ATTENTION 9 0.0002
634 WRIST FRACTURE 2 0.0002
635 GASTROENTERITIS VIRAL 3 0.0002
636 RASH PRURITIC 9 0.0002
637 BLOOD PRESSURE DECREASED 11 0.0002
638 ARTHRITIS 13 0.0002
639 RESTLESS LEGS SYNDROME 3 0.0002
640 NOCTURIA 2 0.0002
641 FIBROMYALGIA 4 0.0002
642 DIZZINESS 82 0.0002
643 BLOOD PRESSURE INCREASED 25 0.0002
644 ACUTE KIDNEY INJURY 25 0.0002
645 ALANINE AMINOTRANSFERASE INCREASED 10 0.0002
646 MUSCLE SPASTICITY 2 0.0002
647 SMALL INTESTINAL OBSTRUCTION 2 0.0002
648 FALL 54 0.0002
649 OROPHARYNGEAL PAIN 15 0.0002
650 PHARYNGITIS 2 0.0002
651 NECK PAIN 9 0.0002
652 ILEUS 2 0.0002
653 TOOTH EXTRACTION 2 0.0002
654 MIDDLE INSOMNIA 3 0.0002
655 MEMORY IMPAIRMENT 22 0.0002
656 PEMPHIGUS 2 0.0002
657 SYNCOPE 16 0.0002
658 BRAIN OEDEMA 2 0.0002
659 CHRONIC KIDNEY DISEASE 12 0.0002
660 PRODUCT COMPLAINT 4 0.0002
661 HYPOTHYROIDISM 5 0.0002
662 WHITE BLOOD CELL COUNT INCREASED 6 0.0002
663 THERAPY CESSATION 8 0.0002
664 ROTATOR CUFF SYNDROME 2 0.0002
665 INFUSION SITE PAIN 2 0.0002
666 HIATUS HERNIA 2 0.0002
667 SKIN EXFOLIATION 13 0.0002
668 PLASMA CELL MYELOMA 6 0.0002
669 SWELLING FACE 10 0.0002
670 RESPIRATORY TRACT INFECTION 4 0.0002
671 PLATELET COUNT INCREASED 2 0.0002
672 KIDNEY INFECTION 3 0.0002
673 MUSCULOSKELETAL PAIN 8 0.0002
674 NEPHROLITHIASIS 7 0.0002
675 MUSCLE SPASMS 28 0.0002
676 TINNITUS 7 0.0002
677 ANKYLOSING SPONDYLITIS 2 0.0002
678 SARS-COV-2 TEST POSITIVE 2 0.0002
679 DEPRESSED MOOD 8 0.0002
680 LIP SWELLING 5 0.0001
681 DRY SKIN 20 0.0001
682 CYTOKINE RELEASE SYNDROME 3 0.0001
683 ATRIOVENTRICULAR BLOCK COMPLETE 1 0.0001
684 JOINT SWELLING 18 0.0001
685 BREAST MASS 1 0.0001
686 FULL BLOOD COUNT DECREASED 3 0.0001
687 BLOOD BILIRUBIN INCREASED 4 0.0001
688 FEEDING DISORDER 3 0.0001
689 ARRHYTHMIA 7 0.0001
690 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 1 0.0001
691 CHEST DISCOMFORT 15 0.0001
692 BLOOD TESTOSTERONE DECREASED 1 0.0001
693 PERIPHERAL COLDNESS 2 0.0001
694 MENTAL STATUS CHANGES 4 0.0001
695 RHABDOMYOLYSIS 6 0.0001
696 DEMENTIA 4 0.0001
697 PAIN IN EXTREMITY 42 0.0001
698 COVID-19 25 0.0001
699 KNEE ARTHROPLASTY 3 0.0001
700 RENAL FAILURE ACUTE 6 0.0001
701 PAIN IN JAW 4 0.0001
702 HEPATOCELLULAR INJURY 2 0.0001
703 SINUS TACHYCARDIA 2 0.0001
704 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 10 0.0001
705 FATIGUE 109 0.0001
706 ELECTROCARDIOGRAM QT PROLONGED 5 0.0001
707 ASTHENIA 52 0.0001
708 MYELODYSPLASTIC SYNDROME 2 0.0001
709 HYPERTHYROIDISM 2 0.0001
710 WRONG TECHNIQUE IN DRUG USAGE PROCESS 5 0.0001
711 FLUID RETENTION 7 0.0001
712 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
713 HYPERGLYCAEMIA 5 0.0001
714 PANIC ATTACK 5 0.0001
715 NEUROPATHY PERIPHERAL 13 0.0001
716 ARTHROPOD BITE 1 0.0001
717 TOOTH DISORDER 3 0.0001
718 ORAL PAIN 3 0.0001
719 SPEECH DISORDER 7 0.0001
720 ATRIAL FIBRILLATION 13 0.0001
721 HEART RATE IRREGULAR 3 0.0001
722 INTESTINAL OBSTRUCTION 5 0.0001
723 ECONOMIC PROBLEM 2 0.0001
724 BLOOD COUNT ABNORMAL 2 0.0001
725 PLATELET COUNT DECREASED 14 0.0001
726 ACIDOSIS 1 0.0001
727 DIARRHOEA 84 0.0001
728 DEVICE RELATED INFECTION 2 0.0001
729 THYROID DISORDER 2 0.0001
730 WEIGHT INCREASED 29 0.0001
731 LIMB DISCOMFORT 4 0.0001
732 OEDEMA 7 0.0001
733 WEIGHT DECREASED 36 0.0001
734 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 1 0.0001
735 APNOEA 1 0.0001
736 BASAL CELL CARCINOMA 2 0.0001
737 PALPITATIONS 15 0.0001
738 HAEMATOCHEZIA 7 0.0001
739 ANAPHYLACTIC REACTION 7 0.0001
740 BLOOD LACTATE DEHYDROGENASE INCREASED 2 0.0001
741 DISORIENTATION 5 0.0001
742 RESPIRATORY TRACT CONGESTION 2 0.0001
743 CYSTITIS 4 0.0001
744 SCIATICA 2 0.0001
745 PRURITUS 48 0.0001
746 CONTUSION 12 0.0001
747 BLISTER 7 0.0001
748 CARDIAC FAILURE CONGESTIVE 10 0.0001
749 NIGHT SWEATS 4 0.0001
750 PAIN 76 0.0001
751 MUSCLE TIGHTNESS 2 0.0001
752 PERIPHERAL SWELLING 19 0.0001
753 MUSCULAR WEAKNESS 14 0.0001
754 BLOOD POTASSIUM INCREASED 2 0.0001
755 BACK DISORDER 2 0.0001
756 LIVER INJURY 3 0.0001
757 SEIZURE 14 0.0001
758 GENERALISED TONIC-CLONIC SEIZURE 2 0.0001
759 NASOPHARYNGITIS 22 0.0001
760 UPPER GASTROINTESTINAL HAEMORRHAGE 2 0.0001
761 GLYCOSYLATED HAEMOGLOBIN INCREASED 3 0.0001
762 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 4 0.0001
763 HAEMATEMESIS 3 0.0001
764 HYPOPHAGIA 3 0.0001
765 HAEMOGLOBIN DECREASED 12 0.0001
766 ILLNESS 12 0.0001
767 MIGRAINE 11 0.0001
768 NERVOUSNESS 6 0.0001
769 BURNING SENSATION 8 0.0001
770 HYPOAESTHESIA 17 0.0001
771 THIRST 2 0.0001
772 ERYTHEMA 23 0.0001
773 MOBILITY DECREASED 8 0.0001
774 THERAPY NON-RESPONDER 5 0.0001
775 LEUKOCYTOSIS 2 0.0001
776 TOOTHACHE 2 0.0001
777 PALLOR 3 0.0001
778 C-REACTIVE PROTEIN INCREASED 4 0.0001
779 SKIN LESION 3 0.0001
780 BRAIN NEOPLASM 1 0.0001
781 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
782 HYPOKALAEMIA 5 0.0001
783 PROCEDURAL PAIN 3 0.0001
784 ABDOMINAL DISCOMFORT 18 0.0001
785 ACCIDENTAL EXPOSURE TO PRODUCT 11 0.0001
786 DYSARTHRIA 4 0.0001
787 PRODUCT DOSE OMISSION IN ERROR 3 0.0001
788 INTERNATIONAL NORMALISED RATIO INCREASED 3 0.0001
789 INSOMNIA 28 0.0001
790 MUSCULOSKELETAL DISORDER 2 0.0001
791 FEELING JITTERY 2 0.0001
792 ANGINA PECTORIS 3 0.0001
793 INCREASED APPETITE 2 0.0001
794 HYPERSOMNIA 3 0.0001
795 FEELING ABNORMAL 25 0.0001
796 LETHARGY 6 0.0001
797 ATELECTASIS 1 0.0001
798 LIVER FUNCTION TEST ABNORMAL 3 0.0001
799 ORAL HERPES 2 0.0001
800 SURGERY 6 0.0001
801 ANXIETY 29 0.0001
802 ACUTE MYOCARDIAL INFARCTION 3 0.0001
803 LABORATORY TEST ABNORMAL 3 0.0001
804 WHITE BLOOD CELL COUNT DECREASED 11 0.0001
805 DISABILITY 2 0.0001
806 DEPRESSED LEVEL OF CONSCIOUSNESS 4 0.0001
807 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
808 HEART RATE INCREASED 10 0.0001
809 BLOOD PRESSURE ABNORMAL 2 0.0001
810 UPPER LIMB FRACTURE 2 0.0001
811 RESPIRATORY DISORDER 3 0.0001
812 PRESCRIBED UNDERDOSE 2 0.0001
813 BRAIN INJURY 1 0.0001
814 HEPATIC FAILURE 3 0.0001
815 APHASIA 3 0.0001
816 CELLULITIS 5 0.0001
817 PRODUCT PHYSICAL ISSUE 2 0.0001
818 VERTIGO 6 0.0001
819 BLINDNESS 4 0.0001
820 FEELING HOT 6 0.0001
821 CHEST PAIN 18 0.0001
822 ALOPECIA 19 0.0001
823 TOOTH LOSS 2 0.0001
824 GASTROINTESTINAL HAEMORRHAGE 8 0.0001
825 MOUTH ULCERATION 2 0.0001
826 HALLUCINATION, VISUAL 2 0.0001
827 BREAST PAIN 1 0.0001
828 MOVEMENT DISORDER 3 0.0001
829 BREAST CANCER METASTATIC 1 0.0001
830 RECTAL HAEMORRHAGE 4 0.0001
831 POOR QUALITY SLEEP 2 0.0001
832 ACNE 7 0.0001
833 DEPRESSION 21 0.0001
834 BIPOLAR DISORDER 1 0.0001
835 PRODUCT DISPENSING ERROR 2 0.0001
836 TREATMENT NONCOMPLIANCE 5 0.0001
837 APPLICATION SITE PAIN 2 0.0001
838 RENAL FAILURE 12 0.0001
839 DEHYDRATION 12 0.0001
840 SKIN DISORDER 3 0.0001
841 URINARY RETENTION 3 0.0001
842 NEOPLASM MALIGNANT 6 0.0001
843 GAIT INABILITY 3 0.0001
844 URTICARIA 15 0.0001
845 RASH 39 0.0001
846 GLOSSODYNIA 2 0.0001
847 THERAPEUTIC PRODUCT EFFECT DECREASED 4 0.0001
848 SNEEZING 2 0.0001
849 THERAPEUTIC RESPONSE UNEXPECTED 4 0.0001
850 PANCREATITIS ACUTE 2 0.0001
851 ANGER 3 0.0001
852 PRODUCT AVAILABILITY ISSUE 2 0.0001
853 GASTRIC DISORDER 3 0.0001
854 SKIN IRRITATION 4 0.0001
855 PERICARDIAL EFFUSION 2 0.0001
856 RASH MACULAR 3 0.0001
857 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 2 0.0001
858 HYPERHIDROSIS 11 0.0001
859 ARTHRALGIA 35 0.0001
860 RASH ERYTHEMATOUS 4 0.0001
861 BLOOD PRESSURE FLUCTUATION 2 0.0001
862 DIABETIC KETOACIDOSIS 2 0.0001
863 INCORRECT DOSE ADMINISTERED 19 0.0001
864 LOCALISED INFECTION 2 0.0001
865 CRYING 3 0.0001
866 STOMATITIS 5 0.0001
867 ADRENAL INSUFFICIENCY 1 0.0001
868 ENCEPHALOPATHY 2 0.0001
869 INFLUENZA 9 0.0001
870 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
871 CONFUSIONAL STATE 13 0.0001
872 APPLICATION SITE IRRITATION 1 0.0001
873 MALAISE 35 0.0001
874 HOT FLUSH 6 0.0001
875 LOSS OF CONSCIOUSNESS 10 0.0001
876 DEATH 67 0.0001
877 BACK PAIN 18 0.0001
878 AMNESIA 5 0.0001
879 DEAFNESS 2 0.0001
880 SEDATION 2 0.0001
881 APPLICATION SITE ERYTHEMA 2 0.0001
882 JOINT STIFFNESS 2 0.0001
883 ABNORMAL BEHAVIOUR 3 0.0001
884 PANCREATITIS 4 0.0001
885 INFUSION RELATED REACTION 5 0.0001
886 ADVERSE REACTION 1 0.0001
887 MYOCARDIAL INFARCTION 13 0.0001
888 EXTRA DOSE ADMINISTERED 3 0.0001
889 THROAT TIGHTNESS 2 0.0001
890 DYSKINESIA 3 0.0001
891 PNEUMONITIS 2 0.0001
892 ACUTE HEPATIC FAILURE 1 0.0001
893 INFLUENZA LIKE ILLNESS 6 0.0001
894 ABDOMINAL PAIN UPPER 15 0.0001
895 RESPIRATORY DISTRESS 2 0.0001
896 ABNORMAL DREAMS 2 0.0001
897 ARTHROPATHY 4 0.0001
898 MYALGIA 12 0.0001
899 SKIN BURNING SENSATION 5 0.0001
900 OVERDOSE 15 0.0001
901 DRUG INTERACTION 11 0.0001
902 INFECTION 10 0.0001
903 FLUSHING 7 0.0001
904 RESPIRATORY FAILURE 5 0.0001
905 PRODUCT STORAGE ERROR 6 0.0001
906 BONE PAIN 4 0.0001
907 CHILLS 8 0.0001
908 GAIT DISTURBANCE 13 0.0001
909 URINARY INCONTINENCE 2 0.0001
910 HAEMORRHAGE 7 0.0001
911 BLOOD POTASSIUM DECREASED 2 0.0001
912 UNEVALUABLE EVENT 5 0.0001
913 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
914 ILL-DEFINED DISORDER 4 0.0001
915 INJECTION SITE SWELLING 5 0.0001
916 DRUG ADMINISTRATION ERROR 2 0.0001
917 ANKLE FRACTURE 1 0.0001
918 COGNITIVE DISORDER 3 0.0001
919 ACUTE MYELOID LEUKAEMIA 1 0.0001
920 BLOOD GLUCOSE INCREASED 12 0.0001
921 ABSCESS 1 0.0001
922 PRODUCT DOSE OMISSION 4 0.0001
923 CARDIAC ARREST 5 0.0001
924 FUNGAL INFECTION 2 0.0001
925 BLOOD UREA INCREASED 1 0.0001
926 TYPE 2 DIABETES MELLITUS 2 0.0001
927 HEPATIC ENZYME INCREASED 4 0.0001
928 INFLAMMATION 3 0.0001
929 EMOTIONAL DISTRESS 7 0.0001
930 NIGHTMARE 2 0.0001
931 DELIRIUM 2 0.0001
932 HYPERKALAEMIA 2 0.0001
933 INJURY 4 0.0001
934 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
935 LYMPHADENOPATHY 2 0.0001
936 PRODUCT ADHESION ISSUE 2 0.0001
937 DEVICE ISSUE 5 0.0001
938 DRUG EFFECT INCOMPLETE 2 0.0001
939 PANCYTOPENIA 3 0.0001
940 CARDIAC DISORDER 5 0.0001
941 PRODUCT USE ISSUE 10 0.0001
942 FLATULENCE 3 0.0001
943 RHEUMATOID ARTHRITIS 6 0.0001
944 PARAESTHESIA 8 0.0001
945 IRRITABILITY 3 0.0000
946 NO ADVERSE EVENT 9 0.0000
947 PSORIATIC ARTHROPATHY 2 0.0000
948 BONE MARROW FAILURE 1 0.0000
949 BODY TEMPERATURE INCREASED 1 0.0000
950 LUNG NEOPLASM MALIGNANT 2 0.0000
951 CARDIO-RESPIRATORY ARREST 2 0.0000
952 RENAL IMPAIRMENT 4 0.0000
953 DECREASED APPETITE 11 0.0000
954 CEREBROVASCULAR ACCIDENT 8 0.0000
955 INTENTIONAL OVERDOSE 3 0.0000
956 DEEP VEIN THROMBOSIS 3 0.0000
957 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
958 DEVICE DISLOCATION 2 0.0000
959 ANGIOEDEMA 2 0.0000
960 TACHYCARDIA 4 0.0000
961 THROMBOCYTOPENIA 5 0.0000
962 NEUTROPENIA 6 0.0000
963 SUICIDAL IDEATION 4 0.0000
964 RENAL DISORDER 2 0.0000
965 DRUG DOSE OMISSION 7 0.0000
966 DISEASE RECURRENCE 2 0.0000
967 AGITATION 3 0.0000
968 AGGRESSION 2 0.0000
969 ABDOMINAL PAIN LOWER 1 0.0000
970 ECZEMA 2 0.0000
971 ANHEDONIA 1 0.0000
972 BRADYCARDIA 2 0.0000
973 DRUG ABUSE 3 0.0000
974 MEDICATION ERROR 2 0.0000
975 PRODUCT SUBSTITUTION ISSUE 2 0.0000
976 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
977 DISEASE PROGRESSION 4 0.0000
978 ADVERSE DRUG REACTION 3 0.0000
979 THERAPEUTIC RESPONSE DECREASED 2 0.0000
980 ADVERSE EVENT 3 0.0000
981 INJECTION SITE ERYTHEMA 4 0.0000
982 EXPOSURE DURING PREGNANCY 2 0.0000
983 MALIGNANT NEOPLASM PROGRESSION 3 0.0000
984 INJECTION SITE BRUISING 2 0.0000
985 TREATMENT FAILURE 2 0.0000
986 COMPLETED SUICIDE 2 0.0000
987 PSORIASIS 3 0.0000
988 MATERNAL EXPOSURE DURING PREGNANCY 2 0.0000
989 BREAST CANCER 2 0.0000
990 INJECTION SITE PAIN 6 0.0000
991 DRUG DEPENDENCE 2 0.0000